NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.



Don't have an account? Subscribe

ADVERTISEMENT

ADVERTISEMENT

NCRI looking to establish new ‘pharma forum’

By Mindo - 21st Feb 2018

According to the NCRI board minutes for last October, the concept of establishing a so-called ‘pharma forum’ was discussed by board members. 

A NCRI spokesperson told the <strong><em>Medical Independent </em></strong>(<strong><em>MI</em></strong>) last week that NCRI “receives no direct pharma funding.” 

“The pharma forum is a joint working concept in its infancy, ie, at preliminary discussion stage,” the NCRI spokesperson told <strong><em>MI</em></strong>. 

“The concept would bring together pharma companies through IPHA (Irish Pharmaceutical Healthcare Association) oversight in support of NCRI infrastructure/strategic projects.” 

The aim, the spokesperson continued, is to identify areas in which NCRI and pharmaceutical companies “share mutual interests and objectives which could lead to accomplishing insufficiently-funded strategic goals based on the NCRI Board and Department of Health approved strategic plan”. 

Separately, the NCRI has told this newspaper that it has agreed the terms of a new lease on its current headquarters in Cork. The issue had been up for discussion in recent months. 

“The terms for a new lease on the Registry’ s offices in Cork Airport Business Park have been agreed with the landlords,” the NCRI spokesperson said. 

“This lease is in the process of being signed.” 

NCRI Director Prof Kerri Clough-Gorr noted in her 2018 New Year message, published at the end of last month (January), that the “NCRI is at a junction”. 

“If our mission, broadly speaking, is to capture the cancer patient experience, then NCRI will need to make some changes,” she wrote. 

“We will first need to decide if NCRI will remain as is, capturing cancer patient information focused on incidence and mortality, or instead tap into our potential to capture the true patient experience (eg, longer follow-up with full treatment and patient outcomes over care pathways and survivorship). 

 “Our organisational review will help us determine which path NCRI will follow into the future.” 

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
The Medical Independent 19th March 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Most Read

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT